ARCHIVES

Nutrition, Disease Oriented Contracts

This article is from The Cancer Letter archive.

Vol. 07 No. 49 | December 4, 1981

Download PDF Visit The Full Archive

Related Articles

NCI Advisors Criticize Plan To Fund R01s On ESA Research With Amgen, J&J Money.

June 27, 2008

Phase III Nexavar Trial Fails Primary Endpoint

August 29, 2014

ODAC Oks Carboplatin As 1st Line Ovarian Therapy; Other Drugs

July 12, 1991

In Brief: Howley, Simone Lead Cancer Policy Board: AMA Campaign Fights Youth Smoking

November 22, 1996

NCI Grant Awards

October 8, 1993

Breast Cancer Coalition Seeks Continued DOD Funding For Research

July 2, 1993